- Home
- ELVN vs UTL Comparison
ELVN vs UTL Comparison
Compare ELVN & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELVN | UTL |
|---|---|---|
| Founded | 2016 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 899.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELVN | UTL |
|---|---|---|
| Price | $21.65 | $47.65 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $41.20 | ★ $55.00 |
| AVG Volume (30 Days) | ★ 511.8K | 127.5K |
| Earning Date | 11-12-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 3.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.85 |
| Revenue | N/A | ★ $502,000,000.00 |
| Revenue This Year | N/A | $5.98 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | ★ N/A | $16.80 |
| Revenue Growth | N/A | ★ 1.03 |
| 52 Week Low | $13.30 | $44.61 |
| 52 Week High | $25.96 | $59.99 |
Technical Indicators
Market Signals| Indicator | ELVN | UTL |
|---|---|---|
| Relative Strength Index (RSI) | 54.55 | 40.22 |
| Support Level | $19.58 | $49.21 |
| Resistance Level | $21.79 | $50.63 |
| Average True Range (ATR) | 1.19 | 1.06 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 57.56 | 15.05 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About UTL UNITIL Corporation
Unitil Corp is a holding company, through its subsidiaries it is engaged in the local distribution of electricity and natural gas throughout its service territories in the states of New Hampshire, Massachusetts, and Maine. The Company has two operating and reportable segments: Utility Electric Operations and Utility Gas Operations. Majority of revenue is gained from Electric Segment.